10.Biotechnology and its Application
normal

Injecting functional adenosine deaminase into a patients (lacking $ADA$ gene) blood cells may be considered as

A

Gene therapy

B

Enzyme replacement therapy

C

Both $(a)$ and $(b)$

D

Genetic engineering

Solution

In $ERT$, patient is given an intravenous injection of $ADA$ or enzyme lacking in the content.
$ADA$ deficient children are wide open to the attacks of viruses and bacteria.

Standard 12
Biology

Similar Questions

Start a Free Trial Now

Confusing about what to choose? Our team will schedule a demo shortly.